Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 22;51(12):4634-4643.
doi: 10.1039/d1dt03896f.

Lewis acid protection turns cyanide containing [FeFe]-hydrogenase mimics into proton reduction catalysts

Affiliations

Lewis acid protection turns cyanide containing [FeFe]-hydrogenase mimics into proton reduction catalysts

Holly J Redman et al. Dalton Trans. .

Abstract

Sustainable sources of hydrogen are a vital component of the envisioned energy transition. Understanding and mimicking the [FeFe]-hydrogenase provides a route to achieving this goal. In this study we re-visit a molecular mimic of the hydrogenase, the propyl dithiolate bridged complex [Fe2(μ-pdt)(CO)4(CN)2]2-, in which the cyanide ligands are tuned via Lewis acid interactions. This system provides a rare example of a cyanide containing [FeFe]-hydrogenase mimic capable of catalytic proton reduction, as demonstrated by cyclic voltammetry. EPR, FTIR, UV-vis and X-ray absorption spectroscopy are employed to characterize the species produced by protonation, and reduction or oxidation of the complex. The results reveal that biologically relevant iron-oxidation states can be generated, potentially including short-lived mixed valent Fe(I)Fe(II) species. We propose that catalysis is initiated by protonation of the diiron complex and the resulting di-ferrous bridging hydride species can subsequently follow two different pathways to promote H2 gas formation depending on the applied reduction potential.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Panel A: The H-cluster, the active site of [FeFe]-hydrogenase, consisting of a [4Fe–4S] cluster fused with the dinuclear [2Fe]H subsite (adapted from entry 6SG2 in the Protein Databank). The black dashed lines represent hydrogen bonding of the cyanide ligands of the [2Fe]H subsite, to amino acids of the protein (P108 and A109; I204 and P203); and the yellow dashes denote linking of the [4Fe–4S]H and [2Fe]H sub-complexes by a bridging cystein thiol. Panel B: Cyanide substituted structural mimics of the [2Fe]H subsite with different central groups in the bridging dithiolate ligand, [Fe2(μ-adt)(CO)4(CN)2]2− (12−) and [Fe2(μ-pdt)(CO)4(CN)2]2− (22−); [Fe2(μ-pdt)(CO)4(CN-BCF)2]2− (32−) is formed upon BCF addition to 22−; and [(μ-H)Fe2(μ-pdt)(CO)4(CN-BCF)2] (4) is a bridging hydride species formed by protonation of 32−.
Fig. 2
Fig. 2. FTIR spectra of studied complexes, 22− (black spectrum), its corresponding borane adduct 32− (red spectrum), and the protonated borane adduct 4 (blue spectrum). Spectra were recorded on 0.5 mM solutions of the complexes in acetonitrile; 4 was prepared by adding 4 eq. of HCl (2 mM) to a 0.5 mM solution of 32−; and 32− was treated with AgNO3 at room temperature to give 5 (green spectrum) IR band frequencies are summarised in Table 1 (corresponding EPR spectra are shown in Fig. S17†).
Fig. 3
Fig. 3. The reduction of 4 followed by FTIR (panel A) and EPR (panel B) spectroscopy. Panel A: FTIR spectra following the addition of CoCp* to complex 4. 5 mM 32− (red spectrum); 5 mM 4 (blue spectrum); 5 mM 4 + 20 mM (4 eq.) CoCp* collected 3 min after mixing (orange spectrum), revealing a mixture of 32− and 4; 5 mM 4 + 20 mM (4 eq.) CoCp* collected 10 min after mixing (magenta spectrum), revealing complete conversion to 32−. The contributions of a possible intermediate at the 3 min time-point is shown as a grey dashed line. Panel B: EPR spectrum following the addition of CoCp* to 4 at −40 °C (green spectrum), showing a mixture of two paramagnetic species; simulated EPR spectrum following addition of CoCp* to 4 (grey dashed line, for details see Fig. S20†) and spectrum recorded following incubation at room temperature for 5 min (magenta spectrum), yielding an EPR silent product.
Scheme 1
Scheme 1. Schematic overview summarising the observed redox and protonation chemistry of 32−. Note that 42− is proposed based on X-band EPR. The chemical reagents employed to trigger a specific reaction are shown, while an electrochemical redox process is indicated by “e”.
Fig. 4
Fig. 4. X-ray absorption spectroscopy data at the Fe K-edge of diiron complexes in MeCN solution. (A and B) X-ray absorption near edge structure (XANES) spectra of indicated complexes. (C) Fe K-edge energies (at 50% level) of the XANES spectra. (D) Fourier-transforms of the extended X-ray absorption fine structure (EXAFS) spectra in (E) of the complexes (black lines, experimental data; coloured lines, simulations with parameters in Table S4†). The annotations refer to the complexes shown in Fig. 1. The spectrum denoted 5 is the result of oxidizing 32− with AgNO3 (5 is also observed by UV-vis and IR spectroscopy in Fig. S13 and S14†). 6 is Fe2(μ-pdt)(CO)6. The black dashed lines in (B and E) show the spectra of 4 after reduction with CoCp to regain 32−.
Fig. 5
Fig. 5. Cyclic voltammograms showing oxidation features of complexes 32− and 4 in acetonitrile. Complex 4 is generated in situ via addition of HCl to a solution of 32−. 5 mM analyte, 0.2 M TBAPF6 (electrolyte), scan rate: 0.1 V s−1, scan window: −1.0 to 0.2 V vs. Fc+/0.
Fig. 6
Fig. 6. Cyclic voltammograms showing the catalytic current response observed when adding HCl to 32− (5 mM) in acetonitrile. The first five titration points are shown; 0 mM HCl (black trace, also in inset); 5 mM HCl (red trace); 10 mM HCl (blue trace); 15 mM HCl (green trace); 20 mM HCl (purple trace). The full titration is shown in the ESI Fig. S22. 0.2 M TBAPF6 (electrolyte), scan rate: 0.1 V s−1, scan window: −1.25 to −2.01 V vs. Fc+/0.

Similar articles

Cited by

References

    1. Madden C. Vaughn M. D. Díez-Pérez I. Brown K. A. King P. W. Gust D. Moore A. L. Moore T. A. J. Am. Chem. Soc. 2012;134:1577–1582. doi: 10.1021/ja207461t. - DOI - PubMed
    1. McCrory C. C. L. Jung S. Ferrer I. M. Chatman S. M. Peters J. C. Jaramillo T. F. J. Am. Chem. Soc. 2015;137:4347–4357. doi: 10.1021/ja510442p. - DOI - PubMed
    1. Land H. Senger M. Berggren G. Stripp S. T. ACS Catal. 2020;10:7069–7086. doi: 10.1021/acscatal.0c01614. - DOI
    1. Kleinhaus J. T. Wittkamp F. Yadav S. Siegmund D. Apfel U.-P. Chem. Soc. Rev. 2021;50:1668–1784. doi: 10.1039/D0CS01089H. - DOI - PubMed
    1. Lubitz W. Ogata H. Rüdiger O. Reijerse E. Chem. Rev. 2014;114:4081–4148. doi: 10.1021/cr4005814. - DOI - PubMed